Nanomedicine Conferences | NanoPharma Conferences 2018 | Nanotechnology Conferences | Pharma Events | Europe Meetings | USA | Asia Events | 2018 | Middle East | Australia

Theme: Emerging Importance of Nanomedicine & Nanotechnology to Drive the Pharma Industry

NanoPharma 2018

Final Program

Renowned Speakers

Vladimir Torchilin
Northeastern University
USA

Gregory Gregoriadis
Xenetic Biosciences Inc.
UK

Angelo Corti
San Raffaele Scientific Institute, Milan
Italy

Fabrizio Pirri
The Polytechnic of Turin
Italy

Bob Irving
Biodetectors Pty Ltd
Australia

Istvan Toth
The University of Queensland
Australia

Igor Chourpa
UniversitÃ© F. Rabelais de Tours
France

Hong Qi Zhang
Hong Kong Baptist University
Hong Kong

Konstantinos Avgoustakis
University of Patras
Greece

Jim Jingjun Huang
Ascendia Pharmaceuticals
USA

Marina V. Zueva
Moscow Helmholtz Research Institute of Eye Diseases
Russia

Katharina M. Fromm
University of Fribourg
Switzerland

Helen O McCarthy
Queenâ€™s University Belfast
UK

Kyle M Jandrasitz
Microfluidics International Corporation, USA
USA

Cristina M Sabliov
Louisiana State University
USA

Christine Charrueau
UniversitÃ© Paris Descartes
France

Seitaro Kamiya
Nagasaki International University
Japan

Gerardo Byk
Bar Ilan University, Israel
Israel

Sophia Hatziantoniou
University of Patras
Greece

Tista Bagchi
University of Delhi
India

Sabrina Gioria
JRC- European Commission, Directorate F â€“ Health, Consumers and Reference Materials
Italy

Ismaeil Haririan
Tehran University of Medical Sciences
Iran

Francesca Ungaro
University of Napoli Federico II
Italy

A J Mixson
University of Maryland School of Medicine
USA

Anne Grobler
North-West University
South Africa

Jonghwi Lee
Chung-Ang University
South Korea

Khaled Greish
Arabian Gulf University
Bahrain

Katja Bettina Ferenz
University of Duisburg-Essen
Germany

Barbara Palazzo
Ghimas S.p.A. c/o Dhitech Scarl, Campus Ecotekne
Italy

Irach B. Taraporewala
President, Sitara Pharmaceutical Group
USA

Galia Blum
The Hebrew University of Jerusalem
Israel

Bruno Sarmento
University of Porto
Portugal

Rossitza Lazova
California Skin Institute
USA

Rene J P Musters
VU University Medical Center
Netherlands

Stephen M Mahler
Australian Institute for Bioengineering and Nanotechnology, University of Queensland
Australia

Yoav D Livney
Israel Institute of Technology
Israel

Jamboor Vishwanatha
UNT Health Science Center
USA

ConferenceSeries Ltd is a renowned organization that organizes highly notable conferences throughout the globe. Currently we are bringing forth “14^th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology” (NanoPharma 2018) scheduled to be held during April 09-11, 2018 at Amsterdam, Netherlands. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmaceutical Nanotechnology and Clinical Trials.

The main theme of the conference is “Emerging Importance of Nanotechnology to Drive the Pharma Industry”.

ConferenceSeries Ltd organizes a conference series of 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

14^th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Nanotechnology and Nanomedicine. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Nanotechnology and Nanomedicine.

Medicine has developed throughout time but has remained forever concerned with the maintenance of health and thus the science of prevention and alleviation, and ultimately curing, of disease. To continue its development in new directions, medicine is now looking to nanomedicine, an emerging scientific specialty born from nanotechnology, which has grown up in the fields of engineering, physics, chemistry and biotechnology, and is now moving into medicine, with huge potential for expansion and development over the next decade and beyond.

As our knowledge of the human body continues to improve, nanotechnology will be developed to monitor, repair and control human biological systems at the molecular level. This conference will offer unique opportunities for developing new therapeutic approaches to diagnose, prevent, treat and eradicate life-threatening diseases and conditions (such as cancer and diabetes), as well as resolving pain and improving medical techniques (such as bone repair and surgical techniques), through various novel nanotechnological approaches.

Nanomedicine is a uniquely addressing the important challenges and advances in medical nanoscale-structured material and devices, biotechnology devices and molecular machine systems and nanorobotics. NanoMed 2018 is a valuable information source for all players in the field – academic, industrial and clinical researchers, pharmaceutical and biotechnology companies, regulatory authorities and others across the scientific community.

Track 1: Nanomedicine and Biomedical Applications:

Nanomedicine is simply the application of nanotechnologies in a healthcare setting and the majority of benefits that have already been seen involve the use of nanoparticles to improve the behaviour of drug substances. Today, nanomedicines are used globally to improve the treatments and lives of patients suffering from a range of disorders including ovarian and breast cancer, kidney disease, fungal infections, elevated cholesterol, menopausal symptoms, multiple sclerosis, chronic pain, asthma and emphysema. The nanomedicines that are currently available are overcoming some of the difficulties experienced by normal medical approaches in delivering the benefit from the drug molecules used. In some cases the drugs have very little solubility in water and the human body struggles to absorb enough to treat the condition. In other cases, the drug molecule is absorbed well but the body removes the drug before it has had long enough to provide a benefit. Drugs may lead to side-effects due to poor delivery at the actual site of disease. For example, drugs that are targeting cancers must avoid healthy tissues and organs or damage can be caused. Nanomedicines therefore can play an important role in ensuring enough of the drug enters the body, that drug that does enter stays in the body for long periods and is targeted specifically to the areas that need treatment.

8th Global Summit on Microbiology & Infectious Diseases, February 22-23, 2018 Paris, France; 17th Annual Congress onPharmaceutics & Drug Delivery Systems, September 20-22, 2018 Prague, Czech Republic; 4th International Conference on Polymer Chemistry, June 25-27, 2018 Stockholm, Sweden; 11th World Microbiology & Immunology Congress, June 28-29, 2018 Amsterdam, Netherlands; 10th International Conference on Chemistry Education, June 21-22, 2018 Oslo, Norway;12th World Congress on Biotechnology and Microbiology, June 28-29, 2018 Amsterdam, Netherlands;14th World Congress on Pharmacology and Drug Safety, August 15-17, 2018 Stockholm, 10th World Congress on Neuropharmacology, August 28-30, 2018 Paris, France; Sweden; 8th World Congress on Chromatography, September 13-14, 2018 Prague, Czech Republic; 9th World Congress on Green Chemistry and Technology, September 17-19, 2018 Amsterdam, Netherlands; 6th European Biopharma Congress, September 18-19, 2018 Amsterdam, Netherlands.

Related Societies:

Societies in USA: American Academy of Nanomedicine, Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nano Medicine International Association of Nanotechnology and Graphene Stakeholders Association

Societies in Europe: Nanotechnology Industries Association, Royal Microscopical Society, Royal Society - Nanotechnology and Nanoscience, British Society for Nanomedicine, European Society for Nanomedicine, French Society for Nanomedicine, European NanoBusiness Association, European Society for Precision Engineering and Nanotechnology, Czech Nanotechnology Industries Association and Erwin Schrödinger Society for Nanosciences

Societies in Asia: National Center for Nanoscience and Technology, Indian Society for Nanomedicine, Nano Technology Research Association and Indian Society of Nanomedicine.

Track 2: Design of Nanodrugs

To date, various nanodrug systems have been developed for different routes of administration, which include dendrimers, nanocrystals, emulsions, liposomes, solid lipid nanoparticles, micelles, and polymeric nanoparticles. Nanodrug systems have been employed to improve the efficacy, safety, physicochemical properties, and pharmacokinetic/pharmacodynamic profile of pharmaceutical substances. In particular, functionalized nanodrug systems can offer enhanced bioavailability of orally taken drugs, prolonged half-life of injected drugs (by reducing immunogenicity), and targeted delivery to specific tissues. Thus, nanodrug systems might lower the frequency of administration while providing maximized pharmacological effects and minimized systemic side effects, possibly leading to better therapeutic compliance and clinical outcomes. In spite of these attractive pharmacokinetic advantages, recent attention has been drawn to the toxic potential of nanodrugs since they often exhibit in vitro and in vivo cytotoxicity, oxidative stress, inflammation, and genotoxicity

Related Societies:

Societies in Asia: National Center for Nanoscience and Technology, Indian Society for Nanomedicine, Nano Technology Research Association and Indian Society of Nanomedicine.

Track 3: Design & Characterization of Nanosystems

Micro and Nanosystems publishes significant original work, topical reviews and guest edited issues ranging from technologies and systems to product innovation and new manufacturing processes with features at the micro and nanoscale. Applications for micro and nanosystems in areas such as health, environment, food, security and consumer goods are covered. The topics to be addressed include Lab-on-a-chip, microfluidics, nano-biotechnology, micro and nanomanufacturing, printed electronics and MEMS.

Related Societies:

Societies in Asia: National Center for Nanoscience and Technology, Indian Society for Nanomedicine, Nano Technology Research Association and Indian Society of Nanomedicine.

Track 4: Nanomedicine and Nanotechnology

Nanomedicine is a branch of medicine that applies the knowledge and tools of nanotechnology to the prevention and treatment of disease. Nanomedicine involves the use of nanoscale materials, such as biocompatible nanoparticles and nanorobots, for diagnosis, delivery, sensing or actuation purposes in a living organism. Nanotechnology has many definitions but in general it is the use and application of materials with sizes in the nanometre range. Just as a millimetre is one-thousandth of a metre, a nanometre is one-millionth of a millimetre. In more understandable terms, a human hair is approximately 80,000 nanometres in diameter and the growing science and industry of nanotechnology utilises materials below 1000 nanometres. Benefits of working at this very small scale have been seen for many years over such diverse areas as electronics and energy storage to sunscreens and food packaging.

Related Societies:

Societies in Asia: National Center for Nanoscience and Technology, Indian Society for Nanomedicine, Nano Technology Research Association and Indian Society of Nanomedicine.

Track 5: Pharmaceutical Nanotechnology

Pharmaceutical Nanotechnology deals with emerging new technologies for developing customized solutions for drug delivery systems. The drug delivery system positively impacts the rate of absorption, distribution, metabolism, and excretion of the drug or other related chemical substances in the body. In addition to this the drug delivery system also allows the drug to bind to its target receptor and influence that receptor’s signaling and activity. Pharmaceutical nanotechnology embraces applications of nanoscience to pharmacy as nanomaterials, and as devices like drug delivery, diagnostic, imaging and biosensor.

Related Societies:

Societies in Asia: National Center for Nanoscience and Technology, Indian Society for Nanomedicine, Nano Technology Research Association and Indian Society of Nanomedicine.

Track 6: Synthesis of Nanoparticles for Drug Delivery

Synthesizing nanoparticles for pharmaceutical purposes such as drug preparation can be done in two methods. Bottom up process such as pyrolysis, inert gas condensation, solvothermal reaction, sol-gel fabrication and structured media in which hydrophobic compound such as liposomes are used as bases to mount the drug. Top down process such as attrition / milling in which the drug is chiseled down to form a nanoparticle.

Related Societies:

Societies in Asia: National Center for Nanoscience and Technology, Indian Society for Nanomedicine, Nano Technology Research Association and Indian Society of Nanomedicine.

Track 7: Regenerative Medicine and Tissue Engineering

Tissue engineering is a branch of regenerative medicine, itself a branch of biomedical engineering. Tissue engineering and regenerative medicine are concerned with the replacement or regeneration of cells, tissues (the focus of tissue engineers) or organs to restore normal biological function.

Related Societies:

Societies in Asia: National Center for Nanoscience and Technology, Indian Society for Nanomedicine, Nano Technology Research Association and Indian Society of Nanomedicine.

Track 8: Drug Delivery Research

Drug delivery is an essential part of pharmaceutical sciences that should be taken into account early in the drug discovery and development process. A drug that cannot be delivered to its site of action is essentially useless. Drug delivery is affected by the physico-chemical properties of the drug and formulation and the interplay of these factors with the transport, binding, and metabolism of the drug in the body. New tools are needed to accurately predict delivery properties of the compounds early during drug discovery, so that the best compounds can be identified for clinical studies. Another class of tools includes the delivery methods that facilitate delivery of hard-to-deliver compounds to the appropriate target sites. Delivery of gene-based drugs (DNA, oligonucleotides, siRNA) and proteins is a major challenge in pharmaceutical science. Nanotechnology can be used to improve drug delivery in these difficult cases. The development and use of nanoparticles in the formulation of these types of drugs is a major focus at CDR, and we welcome productive industrial partnerships to develop these tools for translational use.

Related Societies:

Societies in Asia: National Center for Nanoscience and Technology, Indian Society for Nanomedicine, Nano Technology Research Association and Indian Society of Nanomedicine.

Track 9: Novel Drug Delivery Systems

Novel Drug delivery system is the advance drug delivery system which improve drug potency, control drug release to give a sustained therapeutic effect, provide greater safety, finally it is to target a drug specifically to a desired tissue.

Related Societies:

Societies in Asia: National Center for Nanoscience and Technology, Indian Society for Nanomedicine, Nano Technology Research Association and Indian Society of Nanomedicine.

Track 10: Smart Drug Delivery Technology

With the unprecedented progresses of biomedical nanotechnology during the past few decades, conventional drug delivery systems (DDSs) have been involved into smart DDSs with stimuli-responsive characteristics. Benefiting from the response to specific internal or external triggers, those well-defined nanoplatforms can increase the drug targeting efficacy, in the meantime; reduce side effects/toxicities of payloads, which are key factors for improving patient compliance. In academic field, variety of smart DDSs have been abundantly demonstrated for various intriguing systems, such as stimuli-responsive polymeric nanoparticles, liposomes, metals/metal oxides, and exosomes.

Related Societies:

Societies in Asia: National Center for Nanoscience and Technology, Indian Society for Nanomedicine, Nano Technology Research Association and Indian Society of Nanomedicine.

Track 11: Nano Pharmaceuticals

Nanopharmaceuticals offer the ability to detect diseases at much earlier stages and the diagnostic applications could build upon conventional procedures using nanoparticles. Nanopharmaceuticals represent an emerging field where the sizes of the drug particle or a therapeutic delivery system work at the nanoscale. In the pharmaceutical industry, a long standing issue is the difficulty of delivering the appropriate dose of a particular active agent to specific disease site. Nanopharmaceuticals have enormous potential in addressing this failure of traditional therapeutics which offers site-specific targeting of active agents. Such precision targeting via nanopharmaceuticals reduces toxic systemic side effects, resulting in better patient compliance. In today’s world economy, a pharmaceutical industry faces enormous pressure to deliver high-quality products to patients while maintaining profitability. Therefore pharmaceutical companies are applying nanotechnology to enhance or supplement drug target discovery and drug delivery. Nanopharmaceutical reduces the cost of drug discovery, design & development and enhances the drug delivery process. This results in the improved Research & Development success rate which enables faster introduction of new, cost-effective products to the marketplace.

Related Societies:

Societies in Asia: National Center for Nanoscience and Technology, Indian Society for Nanomedicine, Nano Technology Research Association and Indian Society of Nanomedicine.

Track 12: Nanobiotechnology

Nanobiotechnology, bionanotechnology, and nanobiology are terms that refer to the intersection of nanotechnology and biology. This discipline helps to indicate the merger of biological research with various fields of nanotechnology. Concepts that are enhanced through nanobiology include: nanodevices (such as biological machines), nanoparticles, and nanoscale phenomena that occurs within the discipline of nanotechnology. This technical approach to biology allows scientists to imagine and create systems that can be used for biological research. Biologically inspired nanotechnology uses biological systems as the inspirations for technologies not yet created.

Related Societies:

Societies in Asia: National Center for Nanoscience and Technology, Indian Society for Nanomedicine, Nano Technology Research Association and Indian Society of Nanomedicine.

Track 13: Graphene Medicine

Graphene based materials including pristine graphene sheets, few-layer graphene flakes, and graphene oxide offer a variety of unique, versatile and tunable properties that can be creatively utilised for biomedical applications. Graphene applications in biomedicine are numerous and can be classified into several main areas: transport (delivery) systems, sensors, tissue engineering and biological agents (for example antimicrobials). Potential and promising properties of graphene and 2D materials for developing innovative and revolutionary medical devices that could improve healthcare.

Related Societies:

Societies in Asia: National Center for Nanoscience and Technology, Indian Society for Nanomedicine, Nano Technology Research Association and Indian Society of Nanomedicine.

Track 14: Personalized Nanomedicine

Personalized medicine aims to individualize chemotherapeutic interventions on the basis of ex vivo and in vivo information on patient- and disease-specific characteristics. By noninvasively visualizing how well image-guided nanomedicines-that is, submicrometer-sized drug delivery systems containing both drugs and imaging agents within a single formulation, and designed to more specifically deliver drug molecules to pathologic sites-accumulate at the target site, patients likely to respond to nanomedicine-based therapeutic interventions may be preselected. In addition, by longitudinally monitoring how well patients respond to nanomedicine-based therapeutic interventions, drug doses and treatment protocols can be individualized and optimized during follow-up. Furthermore, noninvasive imaging information on the accumulation of nanomedicine formulations in potentially endangered healthy tissues may be used to exclude patients from further treatment. Consequently, combining noninvasive imaging with tumor-targeted drug delivery seems to hold significant potential for personalizing nanomedicine-based chemotherapeutic interventions, to achieve delivery of the right drug to the right location in the right patient at the right time.

Related Societies:

Societies in Asia: National Center for Nanoscience and Technology, Indian Society for Nanomedicine, Nano Technology Research Association and Indian Society of Nanomedicine.

Track 15: Nanomedicine & Cancer

According to the World Health Organization (WHO), there will be 15 million new cases of cancer worldwide in 2020. More than 90% of cancer-related deaths occur by the spread of malignant cells to vital organs, a process called metastasis. Academia, Pharmaceutical and biotechnology companies are making substantial research investments in order to develop specific treatments that can destroy primary and secondary tumors, i.e. those resulting from metastasis to other organs. Nanotechnology in cancer treatments is already a reality providing a wide range of new tools and possibilities, from earlier diagnostics and improved imaging to better, more efficient, and more targeted therapies.

Related Societies:

Societies in Asia: National Center for Nanoscience and Technology, Indian Society for Nanomedicine, Nano Technology Research Association and Indian Society of Nanomedicine.

Track 16: Regulatory Aspects towards Approval of Nanomedicine and Pharmaceutical Nanotechnology

Nanomedicines have been in the forefront of pharmaceutical research in the last decades, creating new challenges for research community, industry, and regulators. There is a strong demand for the fast development of scientiï¬c and technological tools to address unmet medical needs, thus improving human health care and life quality. Tremendous advances in the biomaterials and nanotechnology ï¬elds have prompted their use as promising tools to overcome important drawbacks, mostly associated to the non-speciï¬c effects of conventional therapeutic approaches. However, the wide range of application of nanomedicines demands a profound knowledge and characterization of these complex products. Their properties need to be extensively understood to avoid unpredicted effects on patients, such as potential immune reactivity. Research policy and alliances have been bringing together scientists, regulators, industry, and, more frequently in recent years, patient representatives and patient advocacy institutions. In order to successfully enhance the development of new technologies, improved strategies for research-based corporate organizations, more integrated research tools dealing with appropriate translational requirements aiming at clinical development, and proactive regulatory policies are essential in the near future.

Related Societies:

Societies in Asia: National Center for Nanoscience and Technology, Indian Society for Nanomedicine, Nano Technology Research Association and Indian Society of Nanomedicine.

Track 17: Nano Pharmaceutical Industry and Market

Nano Pharmaceutical Market report focuses on the major drivers and restraints for the key players. It also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Nano Pharmaceutical Market research report is a professional and in-depth study on the current state of the Nano Pharmaceutical Industry.

Related Societies:

Societies in Asia: National Center for Nanoscience and Technology, Indian Society for Nanomedicine, Nano Technology Research Association and Indian Society of Nanomedicine.

ConferenceSeries Ltd is a renowned organization that organizes highly notable international conferences throughout the globe. Currently we are bringing forth “14^th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology” (NanoMed 2018) scheduled to be held during April 16-18, 2018 at Amsterdam, Netherlands. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmaceutical Nanotechnology and Drug delivery.

The main theme of the conference is “Emerging Importance of Nanotechnology to Drive the Pharma Industry”.

NanoMed 2018 is a unique platform to meet fellow key decision makers and experts all-around the Academic Institutions, Healthcare Institutes, Pharmaceutical, Biotech, Biomedical, Formulation scientists and researchers making the congress a perfect platform to share experience, foster collaborations through the research talks & presentations to put forward many thought provoking strategies. It's a perfect stage to brainstorm, discover new ideas, search for new skills and a platform to show your capabilities and discoveries to the world.

ConferenceSeries Ltd organizes a conference series of 3000+ Global Events with over 1000+ Conferences, 1200+ Symposiums and 1200+ Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Top Reasons to Attend

A unique opportunity to discuss issues of importance and relevance to advancing pharmacy practice through continuous professional development.
The conference is of interest to all those in the Continuing Education/Professional Development experience, including pharmacists, developers, sponsors, faculty, regulators, government, professional associations, pharmaceutical industry, communication companies, and allied health care providers and organizations from around the world.
Meet with key decision makers in the pharmaceutical industry worldwide and learn about the latest innovations, technologies, trends and developments in pharmaceutical industry.
Network and gain access to one of the world's fastest growing pharmaceutical markets.
A momentum is growing world-wide that recognizes the integral role of continuing professional development in Pharmaceutical Industry, and the value of sharing experiences and knowledge in an international, collegial forum.
The conference facilitates participant access to high quality educational programs, internationally significant research and development, and world-renowned leaders in the Pharmaceutical field.
This is the only event featuring renowned speakers and delegates and expertise on the topics you care about most!

Target Audience

Professors, Associate Professors, Asst Professors
PhD Scholars
Graduates and Post Graduates
Directors, CEO’s of Organizations
Association, Association presidents and professionals
Noble laureates in Health Care and Medicine
Bio instruments Professionals
Research Institutes and members
Supply Chain companies
Manufacturing Companies
Training Institutes
Business Entrepreneurs

2018 Highlights:

300+ Participation (70 Industry: 30 Academia)
5+ Keynote Speakers
50+ Plenary Speakers
20+ Exhibitors
14 Innovative Educational Sessions
5+ Workshops
B2B Meetings

Exhibition:

Why exhibit?

Make sales
Debut new products
Profile your brand
Meet new business partners and suppliers
Develop key relationships
Educate healthcare, pharma and biotech institutions and academia

Who you will meet?

Leaders in:

Nanomedicine
Biomedical sciences
Drug Delivery
Formulation
Drug Development
Nanotechnology
QbD
Delivery Devices
Bioavailability
New Products
Pre-Formulation
Process R&D
CMC
Stability
Bio manufacturing
Manufacturing
Solid State Chemistry
Analytical Development
Product Enhancement

Who should sponsor?

Analytical Services
Formulation Development
CMO
Drug Delivery Technologies
Full service CRO
Preformulation testing
Software

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	April 09-11, 2018
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2
Poster Opportunity Closed	Click Here to View